Entering text into the input field will update the search result below

MacroGenics collaborates with Zai Lab to develop bispecific antibodies in oncology

  • MacroGenics (NASDAQ:MGNX) and Zai Lab (NASDAQ:ZLAB) have entered into an exclusive collaboration and license agreement involving up to four immuno-oncology molecules.
  • MacroGenics provides rights to Zai Lab for its DART and TRIDENT multi-specific platforms and a lead research program targeting

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
MGNX
--
ZLAB
--